| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-06 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
6e-06 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
| mRNA |
BHG712 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
9e-05 |
| mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.2 |
0.0001 |
| mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
serdemetan |
FIMM |
pan-cancer |
AAC |
-0.55 |
0.0002 |